|
1
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.
|
|
2
|
Japanese Gastric Cancer Association.
Japanese Classification of Gastric Carcinoma - 2nd English Edition.
Gastric Cancer. 1:10–24. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shiozawa N, Kodama M, Chida T, Arakawa A,
Tur GE and Koyama K: Recurrent death among early gastric cancer
patients: 20 years’ experience. Hepatogastroenterology. 41:244–247.
1994.
|
|
4
|
Kim JP, Hur YS and Yang HK: Lymph node
metastasis as a significant prognostic factor in early gastric
cancer: analysis of 1,136 early gastric cancers. Ann Surg Oncol.
2:308–313. 1995. View Article : Google Scholar
|
|
5
|
Degiuli M and Calvo F: Survival of early
gastric cancer in a specialized European center. Which
lymphadenectomy is necessary? World J Surg. 30:2193–2203. 2006.
View Article : Google Scholar
|
|
6
|
Smith JW, Shiu MH, Kelsey L and Brennan
MF: Morbidity of radical lymphadenectomy in the curative resection
of gastric cancer. Arch Surg. 126:1469–1473. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Crispi S, Calogero RA, Santini M, et al:
Global gene expression profiling of human pleural mesotheliomas:
identification of matrix metalloproteinase 14 (MMP-14) as potential
tumour target. PLoS One. 4:e70162009. View Article : Google Scholar
|
|
8
|
Guo RF, Zang SZ, Fang JY, et al:
Identification of biomarkers for early detection in gastric cancer
and its clinical biological significance. Beijing Da Xue Xue Bao.
41:353–360. 2009.(In Chinese).
|
|
9
|
Fèvre-Montange M, Champier J, Durand A, et
al: Microarray gene expression profiling in meningiomas:
differential expression according to grade or histopathological
subtype. Int J Oncol. 35:1395–1407. 2009.
|
|
10
|
Yoshihara K, Tajima A, Komata D, et al:
Gene expression profiling of advanced-stage serous ovarian cancers
distinguishes novel subclasses and implicates ZEB2 in tumour
progression and prognosis. Cancer Sci. 100:1421–1428. 2009.
View Article : Google Scholar
|
|
11
|
Lau SK, Boutros PC, Pintilie M, et al:
Three-gene prognostic classifier for early-stage non small-cell
lung cancer. J Clin Oncol. 25:5562–5569. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zervakis M, Blazadonakis ME, Tsiliki G, et
al: Outcome prediction based on microarray analysis: a critical
perspective on methods. BMC Bioinformatics. 10:532009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan Z, Xiong Y, Xu W, et al:
Identification of hsa-miR-335 as a prognostic signature in gastric
cancer. PLoS One. 7:e400372012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen C, Ridzon DA, Broomer AJ, et al: Real
time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids
Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
|
|
16
|
Tusher VG, Tibshirani R and Chu G:
Significance analysis of microarrays applied to transcriptional
responses to ionizing radiation. Proc Natl Acad Sci USA.
98:5116–5121. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tan AC, Naiman DQ, Xu L, et al: Simple
decision rules for classifying human cancers from gene expression
profiles. Bioinformatics. 21:3896–3904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liang RQ, Li W, Li Y, et al: An
oligonucleotide microarray for microRNA expression analysis based
on labeling RNA with quantum dot and nanogold probe. Nucl Acids
Res. 33:e172005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Price ND, Trent J, El-Naggar AK, et al:
Highly accurate two-gene classifier for differentiating
gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad
Sci USA. 104:3414–3419. 2007. View Article : Google Scholar
|
|
20
|
Sun M, Liu XH, Li JH, et al: MiR-196a is
upregulated in gastric cancer and promotes cell proliferation by
downregulating p27(kip1). Mol Cancer Ther. 11:842–852. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Niinuma T, Suzuki H, Nojima M, et al:
Upregulation of miR-196a and HOTAIR drive malignant character in
gastrointestinal stromal tumors. Cancer Res. 72:1126–1136. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schimanski CC, Frerichs K, Rahman F, et
al: High miR-196a levels promote the oncogenic phenotype of
colorectal cancer cells. World J Gastroenterol. 15:2089–2096. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kong X, Du Y, Wang G, et al: Detection of
differentially expressed microRNAs in serum of pancreatic ductal
adenocarcinoma patients: miR-196a could be a potential marker for
poor prognosis. Dig Dis Sci. 56:602–609. 2011. View Article : Google Scholar
|
|
24
|
Wang K, Li J, Guo H, et al: MiR-196a
binding-site SNP regulates RAP1A expression contributing to
esophageal squamous cell carcinoma risk and metastasis.
Carcinogenesis. 33:2147–2154. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsai KW, Liao YL, Wu CW, et al: Aberrant
expression of miR-196a in gastric cancers and correlation with
recurrence. Genes Chromosomes Cancer. 51:394–401. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Christensen BC, Avissar-Whiting M, Ouellet
LG, et al: Mature microRNA sequence polymorphism in MIR196A2 is
associated with risk and prognosis of head and neck cancer. Clin
Cancer Res. 16:3713–3720. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song YX, Yue ZY, Wang ZN, et al:
MicroRNA-148b is frequently down-regulated in gastric cancer and
acts as a tumor suppressor by inhibiting cell proliferation. Mol
Cancer. 10:12011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou X, Zhao F, Wang ZN, Song YX, Chang H,
Chiang Y and Xu HM: Altered expression of miR-152 and miR-148a in
ovarian cancer is related to cell proliferation. Oncol Rep.
27:447–454. 2012.PubMed/NCBI
|
|
29
|
Zheng B, Liang L, Wang C, et al:
MicroRNA-148a suppresses tumor cell invasion and metastasis by
downregulating ROCK1 in gastric cancer. Clin Cancer Res.
17:7574–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schultz NA, Andersen KK, Roslind A,
Willenbrock H, Wøjdemann M and Johansen JS: Prognostic microRNAs in
cancer tissue from patients operated for pancreatic cancer - five
microRNAs in a prognostic index. World J Surg. 36:2699–2707. 2012.
View Article : Google Scholar
|
|
31
|
Takahashi M, Cuatrecasas M, Balaguer F, et
al: The clinical significance of MiR-148a as a predictive biomarker
in patients with advanced colorectalcancer. PLoS One. 7:e466842012.
View Article : Google Scholar : PubMed/NCBI
|
